期刊文献+

中药及其成分抗肝脏缺血再灌注损伤的研究进展

Research progress in the treatment of hepatic ischemia-reperfusion injury with traditional Chinese medicines and components
下载PDF
导出
摘要 目的总结近年来中药防治肝缺血再灌注损伤(hepatic ischemia-reperfusion injury,HIRI)的研究进展。方法通过查阅国内外文献,综述中药对HIRI的保护作用,归纳、总结中药防治HIRI的作用机制。结果中药通过抗氧化应激、抗炎症反应、调控细胞自噬和抗细胞凋亡等药理作用有效防治HIRI。结论中药能有效防治HIRI,具有多种抗HIRI机制。 Objective To summarize the research progress of traditional Chinese medicines(TCM)in prevention and treatment of hepatic ischemia reperfusion injury(HIRI)in recent years.Methods By reviewing domestic and foreign literatures,the protective effects of TCM on HIRI were reviewed,summarize and summarize the mechanism of action of traditional Chinese medicine in preventing and treating HIRI.Results TCM can effectively prevent and treat HIRI by anti-oxidative stress,anti-inflammatory reaction,regulation of autophagy and anti-apoptosis.Conclusion TCM can effectively prevent and treat HIRI with a variety of anti-HIRI mechanisms.
作者 郑秀璐 李妮 江艺 ZHENG Xiulu;LI Ni;JIANG Yi(School of Nursing,Fujian University of Chinese Medicine,Fuzhou 350122,China;The 900th Hospital of the Joint Service Support Force of Chinese People’s Liberation Army,Fuzhou 350025,China)
出处 《西北药学杂志》 CAS 2023年第4期221-228,共8页 Northwest Pharmaceutical Journal
基金 福建省引导性项目(编号:2020Y0078)。
关键词 中药(TCM) 肝疾病 缺血再灌注损伤 traditional Chinese medicine(TCM) liver diseases ischemia-reperfusion injury
  • 相关文献

参考文献37

二级参考文献175

共引文献228

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部